Tue, March 12, 2019
Mon, March 11, 2019
Fri, March 8, 2019
Thu, March 7, 2019
Wed, March 6, 2019
Tue, March 5, 2019

Hartaj Singh Maintained (VRTX) at Buy with Increased Target to $230 on, Mar 7th, 2019

Hartaj Singh of Oppenheimer, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $200 to $230 on, Mar 7th, 2019.

Hartaj has made no other calls on VRTX in the last 4 months.



There are 3 other peers that have a rating on VRTX. Out of the 3 peers that are also analyzing VRTX, 1 agrees with Hartaj's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Christopher Raymond of "Raymond James" Downgraded from Buy to Hold on, Wednesday, January 2nd, 2019


These are the ratings of the 2 analyists that currently disagree with Hartaj


  • Robyn Karnauskas of "Citigroup" Maintained at Strong Buy with Decreased Target to $205 on, Friday, January 4th, 2019
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $210 on, Wednesday, December 19th, 2018